NASI #1 and #6 LMLP from yesterday's watch list moves up nicely today also are leaders and today you saw that. LMLP was called yesterday as well. #10 AMKR which had a quick spurt at the end of yesterday's session continued up over 8% again today. HH did not last, so much for stocks on this exchange.
NASI is a biomedical company with a PROFIT GROWTH RANK in the 99th percentile in the entire biotech and medical sector. Its has an EPS rank of 99, which equates to 101% growth estimated in the next 3 years. It's quarterly growth last quarter alone was 222% with only IVGN (a watch list drop out today ;-() high at 300%. The relative strength ranking of NASI is 84 and IVGN's is 95 (which is why I dropped IVGN) IVGN has been up 490% from February 1999 when it IPOed. and NASI was up 132% in the last 12 months.
Watch List for March 21st
1> NASI - NORTH AMERN SCIENTIFIC INC .MED
Price= 24.0 VL/30= 66.5 %Rnge= 81.0 Sto9V= 47.4
W14dV= 57.1 %Hi4 = 76.1 1-Dy = 113.9 50MA = 144.3
21MA = 103.0
Closes at a good high above the close of previous days opening. volume is
lighter than usual but this trend looks nice so far.
6> LMLP - LML PMT SYS INC
Price= 48.6 VL/30= 113.7 %Rnge= 54.0 Sto9V= 93.5
W14dV= 85.9 %Hi4 = 100.0 1-Dy = 108.0 50MA = 240.3
21MA = 154.4
Strong stock, has seen no corrective moves but a steady uptrend since end
of january.. Could be a potential short, but even so, LMLP should be
watched for a possible 7 point or more correction than continuation of
uptrend.. However LMLP never showed any signs of weakening all through yesterday's session, closed nicely and continued up on Wednesday.
North American Scientific Reports Record First-Quarter Revenues and Earnings
143% Increase in Earnings Per Share
65% Increase in Net Sales
CHATSWORTH, Calif.--(BUSINESS WIRE)--Feb. 23, 2000--North American Scientific Inc. (Nasdaq:NASI - news) today announced financial results for its first quarter ended Jan. 31, 2000.
Earnings per share for the first quarter ended Jan. 31, 2000, increased 143%, to $.17 from $.07 for the first quarter a year ago. Net income for the company increased to $1.2 million for the quarter ended Jan. 31, 2000, compared with net income of $510,000 for the comparable quarter of the previous year.
Net sales for the first quarter increased 65% to $4.0 million, as compared with net sales of $2.4 million for the first quarter of the previous year.
``I am pleased with NASI's track record of achieving strong financial results,' said North American Scientific President and CEO Michael Cutrer. ``The results for the first quarter reflect our commitment to improve profitability while simultaneously increasing our market share in the brachytherapy product lines. |
